ストックスクリーナーアプリを入手
1.10
0.90%
-0.01
アフターアワーズ：
1.07
-0.03
-2.73%
前日終値:
$1.11
開ける：
$1.09
24時間の取引高:
24,563
Relative Volume:
0.01
時価総額：
$2.54M
収益：
$8.27M
当期純損益:
$-17.52M
株価収益率:
-0.0176
EPS:
-62.6089
ネットキャッシュフロー:
$-10.90M
1週間 パフォーマンス:
+1.85%
1か月 パフォーマンス:
-31.68%
6か月 パフォーマンス:
-69.44%
1年 パフォーマンス:
-3.51%
1日の値動き範囲:
$1.0301
$1.11
1週間の範囲:
$0.96
$1.1699
52週間の値動き範囲:
$0.19
$25.95
Nuwellis Inc Stock (NUWE) Company Profile
Compare NUWE vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
1.10 | 2.56M | 8.27M | -17.52M | -10.90M | -62.61 |
ABT
Abbott Laboratories
|
104.06 | 182.20B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.51 | 127.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.58 | 111.92B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
68.15 | 103.35B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.69 | 47.64B | 6.07B | 1.06B | 1.34B | 1.8063 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-29 | 開始されました | ROTH MKM | Buy |
Nuwellis Inc (NUWE) 最新ニュース
Investment Report: Does Nuwellis Inc have pricing power2026 EndofYear Setup & Long-Term Safe Return Strategies - baoquankhu1.vn
Nuwellis (NASDAQ: NUWE) director Emerson Martin J submits initial Form 3 - Stock Titan
Nuwellis completes acquisition of Rendiatech for renal monitoring By Investing.com - Investing.com South Africa
CEO Moves: How correlated is VIVK to the S P5002026 Closing Moves & High Accuracy Buy Signal Tips - baoquankhu1.vn
NUWE SEC FilingsNuwellis Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Nuwellis, Inc. completed the acquisition of Rendiatech Ltd. - marketscreener.com
Nuwellis completes acquisition of Rendiatech for renal monitoring - Investing.com
Nuwellis completes acquisition of Rendiatech, expanding technology portfolio - Investing.com
Nuwellis, Inc. Completes Acquisition of Rendiatech, Expanding Automated Kidney Monitoring Technology Portfolio - Minichart
Nuwellis (NUWE) Finalizes Acquisition of Israeli Tech Firm Rendi - GuruFocus
Nuwellis Completes Acquisition of Kidney Monitoring Innovator Rendiatech - TipRanks
Nuwellis Completes Acquisition of Rendiatech - Bitget
Nuwellis (NASDAQ: NUWE) closes deal for Rendiatech kidney monitoring tech - Stock Titan
Nuwellis buys new kidney monitors to guide earlier care for sickest patients - Stock Titan
Nuwellis, Inc. (NASDAQ: NUWE) Q4 2025 earnings call transcript - MSN
Nuwellis (NUWE) Q4 2025 Earnings Call Transcript - AOL.com
Nuwellis, Inc. 2026 Annual Report: Aquadex System Market, Risks, and Regulatory Overview - Minichart
Nuwellis Q4 Earnings Call Highlights - Defense World
Nuwellis 10-K: $8.27M Revenue, $(25.39) Loss Per Share - TradingView
Nuwellis, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 - marketscreener.com
Nuwellis Inc (NUWE) Reports Q4 Earnings - AlphaStreet
Nuwellis Earnings Call: Margin Gains Amid Cash Strain - TipRanks
Earnings call transcript: Nuwellis Q4 2025 sees strategic shifts amid revenue growth - Investing.com Nigeria
Earnings call transcript: Nuwellis Q4 2025 sees strategic shifts amid revenue growth By Investing.com - Investing.com South Africa
Nuwellis (NUWE) Q4 2025 revenue rises 4% as yearly loss widens - Stock Titan
Nuwellis, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Nuwellis (NUWE) Reports Increased Q4 Revenue Amidst Strategic Re - GuruFocus
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results - Bitget
BRIEF-Nuwellis Q4 EPS USD -1.5 - TradingView
Nuwellis Q4 2025 Earnings Call Transcript - MarketBeat
Nuwellis Earnings Preview - Benzinga
Nuwellis Inc expected to post a loss of $1.56 a shareEarnings Preview - TradingView
Nuwellis appoints Stuart Goldstein as clinical strategy director By Investing.com - Investing.com Canada
Nuwellis appoints Stuart Goldstein as clinical strategy director - Investing.com Nigeria
Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy - Bitget
NUWEForm PRE 14AOther preliminary proxy statements - ADVFN Ltd
Nuwellis (NUWE) director David McDonald reports nonstatutory option holdings - Stock Titan
NUWE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
NUWE Technical Analysis & Stock Price Forecast - Intellectia AI
Nuwellis adds two directors with medical device experience By Investing.com - Investing.com Australia
Nuwellis Expands Board With New Independent Financial Experts - TipRanks
Nuwellis adds two directors with medical device experience - Investing.com
Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors - The Manila Times
Nuwellis Inc (NUWE) 財務データ
収益
当期純利益
現金流量
EPS
1.69%
0.33%
大文字化:
|
ボリューム (24 時間):